Drug & intervention
aliskiren 300 MG / hydrochlorothiazide 25 MG Oral Tablet [Tekturna HCT]
RxCUI 1011755
What this record represents
SBD · RxNormThis is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
Tekturna HCTBN · CureCurrent ID 56454
aliskiren / hydrochlorothiazide Oral Tablet [Tekturna HCT]SBDF · CureCurrent ID 38686
aliskiren 150 MG / hydrochlorothiazide 25 MG [Tekturna HCT]SBDC · CureCurrent ID 47822
aliskiren 300 MG / hydrochlorothiazide 25 MG [Tekturna HCT]SBDC · CureCurrent ID 47834
aliskiren 150 MG / hydrochlorothiazide 12.5 MG [Tekturna HCT]SBDC · CureCurrent ID 47819
aliskiren 300 MG / hydrochlorothiazide 12.5 MG [Tekturna HCT]SBDC · CureCurrent ID 47831
aliskiren 150 MG / hydrochlorothiazide 25 MG Oral Tablet [Tekturna HCT]SBD · CureCurrent ID 47823
aliskiren 150 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Tekturna HCT]SBD · CureCurrent ID 47820
aliskiren 300 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Tekturna HCT]SBD · CureCurrent ID 47832
Advertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.